Format

Send to

Choose Destination
Med Princ Pract. 2008;17(2):131-5. doi: 10.1159/000112967. Epub 2008 Feb 19.

Effects of cyanocobalamin on immunity in patients with pernicious anemia.

Author information

1
Department of Hematology, Faculty of Medicine, Inonu University, Malatya, Turkey. maerkurt@inonu.edu.tr

Abstract

OBJECTIVE:

The aim of the study was to evaluate the role of vitamin B(12) in patients with pernicious anemia.

MATERIALS AND METHODS:

This study was conducted prospectively at the Turgut Ozal Medical Center, Department of Hematology, between April and November 2002. Absolute numbers and ratio of the surface antigens of T and B lymphocyte subgroups, CD4/CD8 ratio were calculated in order to evaluate changes in leukocyte and lymphocyte numbers; natural killer (NK) cell count, serum C3, C4, and levels of immunoglobulins G, A, and M were also measured to evaluate vitamin B(12) effect on immunity. Values obtained before treatment with cyanocobalamin were compared with those found during peak reticulocyte count.

RESULTS:

In vitamin B(12)-deficient patients, absolute numbers of CD4+ and especially CD8+ lymphocytes were found to be decreased; CD4/CD8 ratio increased, and NK cell activity was depressed. After cyanocobalamin treatment, absolute numbers and percentage of lymphocyte subgroups were elevated. Increased CD4/CD8 ratio and depressed NK cell activity were restored and levels of C3, C4, and immunoglobulins were elevated.

CONCLUSION:

These findings suggest that vitamin B(12) has important immunomodulatory effects on cellular immunity, and abnormalities in the immune system in pernicious anemia are restored by vitamin B(12) replacement therapy.

PMID:
18287797
DOI:
10.1159/000112967
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center